3.17
Adverum Biotechnologies Inc Azioni (ADVM) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
-
|
- | - | 1.00 | - |
|
3.39%
49.85
|
48.22 | 42.62 | 35.44 | 32.90 |
Depreciation and Amortization |
21.67%
0.535
|
0.683 | 0.81 | 0.89 | 0.956 |
Operating Income/Loss |
3.39%
-49.85
|
-48.22 | -42.62 | -34.44 | -32.90 |
Income/Loss From Continuing Operations Before Tax |
4.62%
-49.19
|
-47.02 | -60.53 | -27.13 | -18.48 |
Income/Loss From Continuing Operations After Tax |
4.62%
-49.19
|
-47.02 | -40.93 | -32.35 | -30.50 |
|
4.62%
-49.19
|
-47.02 | -40.93 | -32.35 | -30.50 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.34%
21.01
|
20.94 | 0.374 | 20.88 | 20.85 |
Diluted Average Shares |
0.34%
21.01
|
20.94 | 0.374 | 20.88 | 20.85 |
Basic Earnings Per Share |
4.00%
-2.34
|
-2.25 | -1.98 | -1.55 | -1.46 |
Diluted Earnings Per Share |
4.00%
-2.34
|
-2.25 | -1.98 | -1.55 | -1.46 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):